{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29117618", "DateCompleted": {"Year": "2018", "Month": "09", "Day": "25"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "11", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1055/s-0043-119751"], "Journal": {"ISSN": "1439-3646", "JournalIssue": {"Volume": "126", "Issue": "4", "PubDate": {"Year": "2018", "Month": "Apr"}}, "Title": "Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association", "ISOAbbreviation": "Exp Clin Endocrinol Diabetes"}, "ArticleTitle": "The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.", "Pagination": {"StartPage": "222", "EndPage": "228", "MedlinePgn": "222-228"}, "Abstract": {"AbstractText": ["This study was conducted to evaluate the effects of flaxseed oil omega-3 fatty acids supplementation on metabolic status of patients with polycystic ovary syndrome (PCOS).", "This randomized double-blind, placebo-controlled trial was conducted on 60 women with PCOS according to the Rotterdam criteria aged 18-40 years old. Participants were randomly assigned into two groups to receive either 1,000\u2009mg flaxseed oil omega-3 fatty acids (n=30) or placebo (n=30) twice a day for 12 weeks. Metabolic, endocrine, inflammatory factors were quantified at baseline and after the 12-week intervention.", "After the 12-week intervention, compared to the placebo, flaxseed oil omega-3 supplementation significantly decreased insulin values (-2.6\u00b17.7 vs.+1.3\u00b13.9\u2009\u00b5IU/mL, P=0.01), homeostasis model of assessment-estimated insulin resistance (-0.7\u00b11.7 vs.+0.3\u00b10.9, P=0.01), mF-G scores (-1.2\u00b11.7 vs. -0.1\u00b10.4, P=0.001), and increased quantitative insulin sensitivity check index (+0.01\u00b10.02 vs. -0.01\u00b10.02, P=0.01). In addition, supplementation with flaxseed oil omega-3 resulted in significant decreases in serum triglycerides (-5.1\u00b120.9 vs.+9.7\u00b126.1\u2009mg/dL, P=0.01), VLDL-cholesterol (-1.0\u00b14.2 vs.+1.9\u00b15.2\u2009mg/dL, P=0.01) and high-sensitivity C-reactive protein (hs-CRP) (-1.6\u00b13.1 vs.+0.2\u00b11.5\u2009mg/L, P=0.004) compared to the placebo. We did not see any significant effect of flaxseed oil omega-3 supplementation on hormonal and other lipid profiles, and plasma nitric oxide levels.", "Overall, flaxseed oil omega-3 supplementation for 12 weeks in women with PCOS had beneficial effects on insulin metabolism, mF-G scores, serum triglycerides, VLDL-cholesterol and hs-CRP levels, but did not affect hormonal and other lipid profiles, and plasma nitric oxide levels."], "CopyrightInformation": "\u00a9 Georg Thieme Verlag KG Stuttgart \u00b7 New York."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, I.R. Iran."}], "LastName": "Mirmasoumi", "ForeName": "Golara", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, I.R. Iran."}, {"Identifier": [], "Affiliation": "Department of Biology, Pyamenoor University, Tehran, Iran."}], "LastName": "Fazilati", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Foroozanfard", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Vahedpoor", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Mahmoodi", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran."}], "LastName": "Taghizadeh", "ForeName": "Mohsen", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran."}], "LastName": "Esfeh", "ForeName": "Nazanin Kazemi", "Initials": "NK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran."}], "LastName": "Mohseni", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Barij Medicinal Plants Research Center, Kashan, I.R. Iran."}], "LastName": "Karbassizadeh", "ForeName": "Hassan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran."}], "LastName": "Asemi", "ForeName": "Zatollah", "Initials": "Z"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Exp Clin Endocrinol Diabetes", "NlmUniqueID": "9505926", "ISSNLinking": "0947-7349"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Fatty Acids, Omega-3"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipids"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "8001-26-1", "NameOfSubstance": "Linseed Oil"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["blood"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Fatty Acids, Omega-3"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Insulin"}, {"QualifierName": ["physiology"], "DescriptorName": "Insulin Resistance"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Linseed Oil"}, {"QualifierName": ["blood"], "DescriptorName": "Lipids"}, {"QualifierName": ["blood"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["blood"], "DescriptorName": "Polycystic Ovary Syndrome"}, {"QualifierName": [], "DescriptorName": "Young Adult"}], "CoiStatement": "None."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29117618", "10.1055/s-0043-119751"]}}]}